Budesonide Capsule, Delayed Release
Product Images NDC 53746-778

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 53746-778). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Of New York Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Budesonide Delayed Release Capsules 1)

1 (Budesonide Delayed Release Capsules 1)
Chemical structure of budesonide, showing its carbon, hydrogen, and oxygen atoms arranged in steroidal framework with specific hydroxyl and ketone functional groups.*
FDA Label Image

1 (Budesonide Delayed Release Capsules 2)

1 (Budesonide Delayed Release Capsules 2)
Label for Budesonide Delayed-Release Capsules 3 mg by Amneal Pharmaceuticals of New York LLC. The label states the product contains 100 capsules and is Rx only. It includes storage instructions, manufacturer and distributor details, a barcode, and a QR code linking to patient information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.